Tolerability of inhaled N-chlorotaurine in humans: a double-blind randomized phase I clinical study.

Arnitz R, Stein M, Bauer P, Lanthaler B, Jamnig H, Scholl-Bürgi S, Stempfl-Al-Jazrawi K, Ulmer H, Baumgartner B, Embacher S, Geisler S, Gostner JM, Müllinger B, Kälz B, Nagl M

Open source

DOI
10.1177/1753466618778955
Published
2018 Jan-Dec
Container
Therapeutic advances in respiratory disease
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1177/1753466618778955,
  title = {Tolerability of inhaled N-chlorotaurine in humans: a double-blind randomized phase I clinical study.},
  author = {Arnitz R and Stein M and Bauer P and Lanthaler B and Jamnig H and Scholl-Bürgi S and Stempfl-Al-Jazrawi K and Ulmer H and Baumgartner B and Embacher S and Geisler S and Gostner JM and Müllinger B and Kälz B and Nagl M},
  year = {2018},
  journal = {Therapeutic advances in respiratory disease},
  doi = {10.1177/1753466618778955},
  url = {https://doi.org/10.1177/1753466618778955}
}

RIS

TY  - JOUR
TI  - Tolerability of inhaled N-chlorotaurine in humans: a double-blind randomized phase I clinical study.
AU  - Arnitz R
AU  - Stein M
AU  - Bauer P
AU  - Lanthaler B
AU  - Jamnig H
AU  - Scholl-Bürgi S
AU  - Stempfl-Al-Jazrawi K
AU  - Ulmer H
AU  - Baumgartner B
AU  - Embacher S
AU  - Geisler S
AU  - Gostner JM
AU  - Müllinger B
AU  - Kälz B
AU  - Nagl M
PY  - 2018
JO  - Therapeutic advances in respiratory disease
DO  - 10.1177/1753466618778955
UR  - https://doi.org/10.1177/1753466618778955
ER  - 

APA

R, A., M, S., P, B., B, L., H, J., S, S., K, S., H, U., B, B., S, E., S, G., JM, G., B, M., B, K., & M, N. (2018). Tolerability of inhaled N-chlorotaurine in humans: a double-blind randomized phase I clinical study.. Therapeutic advances in respiratory disease. https://doi.org/10.1177/1753466618778955

Source records